drugset / Trial / NCT02673372

Geriatric Ketamine for Pain Management Study

NCT02673372 ↗

Phase 4 Completed 60 enrolled Antonios Likourezos
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This research project is geared towards geriatric analgesia in the Emergency Department (ED) with a goal of reducing the administration of opioid pain medications to elderly patients, thereby avoiding the commonly occurring, severe side effects associated with such medications, including hypotension, respiratory depression, altered mental status, delirium, as well as nausea/vomiting and constipation. The primary outcome of the study will be difference in pain score from baseline to 30 minutes post-medication administration. This project has the potential to change and modify the ED approach to geriatric analgesia by virtue of minimizing the use of opioid administration in elderly patients. T

Timeline

Start
2016-04
Primary completion
2018-02
Completion
2018-04

Outcome

Missed primary endpoint

paper The primary change in mean pain scores was not significantly different in the ketamine and morphine groups PMID 29807629 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.3 mg/kg Intravenous
Comparator Morphine Other / unclassified 0.1 mg/kg Intravenous

Indications

No indication recorded.